布地奈德
计量吸入器
医学
福莫特罗
慢性阻塞性肺病
恶化
慢性阻塞性肺病加重期
吸入器
肺炎
布地奈德/福莫特罗
吸入
麻醉
哮喘
内科学
慢性阻塞性肺疾病急性加重期
作者
Klaus F. Rabe,F.J. Martinez,Gary T. Ferguson,Dave Singh,Jadwiga A. Wedzicha,Martin Jenkins,Magnus Aurivillius,Colin Reisner,Paul Dorinsky
出处
期刊:Pneumologie
[Georg Thieme Verlag KG]
日期:2021-04-01
标识
DOI:10.1055/s-0041-1723286
摘要
Background: In the Phase III, 52-week ETHOS study (NCT02465567), budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) fixed-dose combination significantly reduced exacerbations vs. dual therapies. However, use of inhaled corticosteroids (ICS) may also increase pneumonia risk.
科研通智能强力驱动
Strongly Powered by AbleSci AI